Viewing StudyNCT00086541



Ignite Creation Date: 2024-05-05 @ 11:35 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00086541
Status: COMPLETED
Last Update Posted: 2019-11-25
First Post: 2004-07-02

Brief Title: Daily-Dose Consensus Interferon and Ribavirin Efficacy of Combined Therapy
Sponsor: Bausch Health Americas Inc
Organization: Bausch Health Americas Inc

Conditions & Keywords Data

Conditions:
Name
Chronic Hepatitis C
Keywords:
Name View
SVR View
Chronic Hepatitis C View
Liver View
Pegylated View
Interferon View
Alpha View
Ribavirin View
Combination View
Nonresponder View
HCV View
Infergen View